Cargando…
Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab
BACKGROUND: Modulation of the immune system to prevent lung injury is being widely used against the new coronavirus disease (COVID-19). The primary endpoint was mortality at 7 days after tocilizumab administration. Secondary endpoints were admission to the intensive care unit, development of ARDS an...
Autores principales: | Sánchez-Montalvá, Adrián, Sellarés-Nadal, Júlia, Espinosa-Pereiro, Juan, Fernández-Hidalgo, Nuria, Pérez-Hoyos, Santiago, Salvador, Fernando, Durà, Xavier, Miarons, Marta, Antón, Andrés, Eremiev-Eremiev, Simeón, Sempere-González, Abiu, Monforte-Pallarés, Arnau, Bosch-Nicolau, Pau, Augustin, Salvador, Sampol, Júlia, Guillén-del-Castillo, Alfredo, Almirante, Benito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448395/ https://www.ncbi.nlm.nih.gov/pubmed/34544604 http://dx.doi.org/10.1016/j.medcli.2021.06.012 |
Ejemplares similares
-
Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2022) -
COVID-19 Clinical Profile in Latin American Migrants Living in Spain: Does the Geographical Origin Matter?
por: Sempere, Abiu, et al.
Publicado: (2021) -
Pulmonary Cryptococcosis Mimicking Lung Cancer
por: Eremiev, Simeon, et al.
Publicado: (2022) -
Incidence and risk factors for early readmission after hospitalization for SARS-CoV-2 infection: results from a retrospective cohort study
por: Kirkegaard, Cristina, et al.
Publicado: (2021) -
Association Between Trypanosoma cruzi DNA in Peripheral Blood and Chronic Chagasic Cardiomyopathy: A Systematic Review
por: Bosch-Nicolau, Pau, et al.
Publicado: (2022)